This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background and Objectives Seizure outcome after extratemporal lobe epilepsy (exTLE) surgery has often been poorer than after temporal lobe epilepsy (TLE) surgery, but recent improvements in diagnostics and surgery may have changed this. Our aim was to analyze the changes in presurgical and surgical volumes and seizure outcome 2 years after surgery for patients with exTLE compared with those with TLE.
Methods We performed a retrospective, single-center cohort study including patients from the Bethel presurgical-surgical-postsurgical database from 1990 to 2017. We used logistic regression to analyze factors influencing the odds for surgery and the odds for seizure freedom after surgery.
Results We included 3,822 patients with presurgical evaluation, 2,404 of whom had subsequently undergone surgery. The proportion of patients with exTLE in presurgical evaluation increased from 41% between 1990 and 1993 to 64% in 2014–2017. The odds for surgery decreased over time (2003–2011: odds ratio [OR] 0.50 [95% CI 0.36–0.70]; 2012–2017: OR 0.24 [CI 0.17–0.35]; reference: 1990–2002) and patients with exTLE had lower odds for surgery than patients with TLE, but this difference diminished over time (exTLE vs TLE 1990–2002: OR 0.14 [CI 0.09–0.20]; 2003–2011: OR 0.32 [CI 0.24–0.44]; 2012–2017: OR 0.46 [CI 0.34–0.63]). Etiology, the side of the epileptogenic lesion, and invasive recordings influenced the odds for surgery. The most frequent reasons for not undergoing surgery were missing identification of a circumscribed epileptogenic zone or an unacceptable risk of postsurgical deficits in patients with exTLE and the patient's decision in patients with TLE. Compared with patients with TLE, the odds for seizure freedom after surgery started lower for patients with exTLE in earlier years, but increased (≤2 lobes 1990–2002: OR 0.47 [CI 0.33–0.68]; 2003–2011: OR 0.62 [CI 0.44–0.87]; 2012–2017: OR 0.78 [CI 0.53–1.15]; ≥3 lobes 1990–2002: OR 0.37 [CI 0.22–0.62]; 2003–2011: OR 0.73 [CI 0.43–1.23]; 2012–2017: OR 1.46 [CI 0.91–2.42]). Etiology, age at surgery, and invasive recordings were further predictors for the odds for seizure freedom.
Discussion Over the past 28 years, the success of resective surgery for patients with exTLE has improved. At the same time, the number of patients with exTLE being evaluated for surgery increased, as well as their odds for undergoing surgery.
Glossary
- exTLE=
- extratemporal lobe epilepsy;
- EZ=
- epileptogenic zone;
- FCD=
- focal cortical dysplasia;
- GLM=
- generalized linear model;
- LEAT=
- low-grade epilepsy-associated tumor;
- MCD=
- malformation of cortical development (other than focal cortical dysplasia or diffuse hemispheric);
- MTS=
- medial temporal sclerosis;
- OR=
- odds ratio;
- TL=
- temporal lobe;
- TLE=
- temporal lobe epilepsy;
- TSC=
- tuberous sclerosis complex
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Barbara Jobst, MD, PhD, FAAN.
- Received July 27, 2021.
- Accepted in final form January 27, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
